Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

280.66
Delayed Data
As of Jan 20
 +0.31 / +0.11%
Today’s Change
223.02
Today|||52-Week Range
333.65
-1.03%
Year-to-Date
7 Stocks for 2017
Jan 20 / GuruFocus News - Paid Partner Content
4 Top Biotech Mutual Funds for 2017
Jan 18 / Zacks.com - Paid Partner Content
So Much For The Bounce: IBB, Down 0.85%, Is Todays Biggest ETF Loser
Jan 19 / Investing Channel - Paid Partner Content
The Zacks Analyst Blog Highlights: Microsoft, Biogen, Home Depot, Bristol-Myers and B...
Jan 18 / Zacks.com - Paid Partner Content
Rockefeller Financial Services Inc Buys Facebook Inc, Synchrony Financial, Cemex SAB ...
Jan 19 / GuruFocus News - Paid Partner Content
Biogen to Pay $1.25B to Forward Pharma in Tecfidera Lawsuit
Jan 18 / Zacks.com - Paid Partner Content
Biogen (BIIB) Q4 Earnings: What's in Store for the Stock?
Jan 19 / Zacks.com - Paid Partner Content
Why Forward Pharma A/S Stock Gained 48.2% on Tuesday
Jan 18 / MotleyFool.com - Paid Partner Content
Alcobra Stock Down on Poor Late-Stage Data on ADHD Drug
Jan 18 / Zacks.com - Paid Partner Content
Merrimack (MACK) Goes Uphill: Is a Turnaround Likely?
Jan 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close280.35
Today’s open282.07
Day’s range279.41 - 282.56
Volume1,979,109
Average volume (3 months)1,640,991
Market cap$61.0B
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+24.01%
Earnings growth (this year)+18.71%
Earnings growth (next 5 years)+9.50%
Revenue growth (last year)+8.60%
P/E ratio15.9
Price/Sales7.60
Price/Book6.54

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.56-0.78%
ILMNIllumina Inc-0.84-0.52%
AMGNAmgen+0.87+0.57%
ARIAARIAD Pharmaceutical...+0.05+0.21%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateJanuary 26, 2017
EPS forecast (this quarter)$4.98
Annual revenue (last year)$9.3B
Annual profit (last year)$3.5B
Net profit margin38.05%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
Chief Financial Officer &
Executive Vice President
Paul J. Clancy
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs